The biopharmaceutical sector has struggled with a prolonged downturn in recent years but has been on an upswing of late.

Summer is winding down, and “spooky season” will soon be upon us. That’s just one cause for investor wariness.

These stocks, and others, in the S&P 500 industrial sector have shown strong price momentum, while the companies are expected ...

The vaccine candidate pairs an mRNA therapy with the cancer drug Keytruda.

Following a sharp selloff in recent months, the South Korean memory-chip company says current share prices don’t reflect the ...

Google will also get the option to purchase about $12 billion worth of Marvell’s stock.

Dear Help Me Retire, I’m looking to help my grandchildren with their retirement. My plan for them is to put the money in a ...

Fundstrat’s Mark Newton says it’s not time to panic about surging bond yields driving a deeper stock rout. He offers ...

I wear multiple hats for my 93-year-old mother-in-law, who has dementia. I am her financial power of attorney (her son is her ...

Shares of Unitree Robotics soared in their Shanghai trading debut as investors piled into the first humanoid-robotics company ...

The retailer has added more snacks and changed its presentation as it tries to become a destination for food purchases.

Balance requirements: $5,000 required to earn highest APY, however a $100 minimum opening deposit to open an account; no ...